Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 756

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 756
---
 on June 1, 2024. The RSUs were valued using the closing price of the Company’s common stock on the date of issuance with the total expense of $186 being recognized over the vesting period of one year. As of June 30, 2024, 4 RSU had vested and were converted to common shares, and 60 RSU had vested but were converted to common shares subsequent to June 30, 2024. F-23

During the year ended June 30, 2024, the Company recognized a total of $171 (2023 - $90) related to RSU.

| Balance – June 30, 2022               |     | Number of      
 RSU            
 (in thousands) |  — |   |
|:--------------------------------------|:----|:---------------|---:|:--|
| Issuance                              |     |                | 78 |   |
| Balance – June 30, 2023               |     |                | 78 |   |
| Vested and converted to common shares |     |                | (4 | ) |
| Forfeited                             |     |                | (8 | ) |
| Balance – June 30, 2024               |     |                | 66 |   |

Common stock warrants The following table sets forth changes in outstanding warrants:

| Balance – June 30, 2022                    
 Expiry of 2018 Investor and Agent warrants |     | Number of      
 warrants       
 (in thousands) | 720 
  (7 | ) |     | Weighted 
 average  
 exercise 
 price    
 $        |  49.36 
 625.68 |
|:-------------------------------------------|:----|:---------------|----:|:--|:----|:---------|-------:|
| Balance – June 30, 2023                    |     |                | 713 |   |     |          |  43.55 |
| Expiry of warrants issued for services     |     |                | (20 | ) |     |          |  71.53 |
| Expiry of 2019 Investor and Agent warrants |     |                | (16 | ) |     |          | 157.25 |
| Balance – June 30, 2024                    |     |                | 677 |   |     |          |  39.99 |

The following table summarizes the Company’s outstanding warrants as of June 30, 2024